SRTA

#2909
Strata Critical Medical, Inc. - Class A Common Stock
5.7 5 USD
-0.04%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
5.74
5.76
Jahresspanne
3.85
6.50
Tagesänderung
-3.69%
Monatliche Änderung
+13.86%
6 month change
+36.90%
Jahresänderung
+33.10%
Vorheriger Schlusskurs
5.9 7
Open
5.7 5
Tief
5.7 4
Hoch
5.7 6
Volumen
36
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Strata Critical Medical, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Strata Critical Medical, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Strata Critical Medical, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Strata Critical Medical, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K

Strata Critical Medical, Inc. current report, Q1 FY2024

Full document

Business Context and Reporting Period

This Form 8-K is a current report filed by Blade Air Mobility, Inc. (not Strata Critical Medical, Inc.) on March 22, 2024. The filing addresses a change in the company's independent registered public accounting firm.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance and audit matters rather than financial performance data.

Material Changes

  • Dismissal of Auditor: On March 19, 2024, the Audit Committee dismissed Marcum LLP, which had served as the independent auditor from October 20, 2020, through March 18, 2024.
  • Appointment of New Auditor: On March 20, 2024, the Audit Committee appointed Deloitte & Touche LLP as the new independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • Audit Opinions: Marcum's reports for the years ended December 31, 2023, and 2022, did not contain adverse opinions, disclaimers, or qualifications.
  • Disagreements: There were no disagreements with Marcum regarding accounting principles or practices. The only "reportable event" noted was the disclosure of a material weakness in internal controls over financial reporting, previously disclosed in the 2023 Form 10-K.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk highlighted is the previously disclosed material weakness in internal controls over financial reporting. No unusual items or contingencies related to financial operations are described in this document.

Investor Verification Checklist

  • Verify the details of the material weakness in internal controls over financial reporting disclosed in the 2023 Form 10-K.
  • Review the letter from Marcum LLP (Exhibit 16.1) to confirm their agreement with the company's statements regarding the dismissal.
  • Confirm the execution of the engagement letter with Deloitte & Touche LLP to finalize the appointment.
  • Monitor future filings for any impact of the auditor change on the audit timeline or financial statement release dates.